What is Cellmyx?
Headquartered in Carlsbad, California, Cellmyx operates at the intersection of biotechnology and surgical precision. The company specializes in the design and manufacturing of high-grade adipose harvesting equipment. Its product portfolio, which includes advanced aspiration tubing and disposable fat transferring systems, addresses critical needs in regenerative medicine and aesthetic surgery. By maintaining a focus on high-quality, single-use medical components, Cellmyx has established itself as a reliable partner for clinical practitioners seeking efficient and sterile solutions for fat grafting procedures. The company's commitment to engineering excellence ensures that its hardware meets the rigorous standards required for modern surgical environments.
How much funding has Cellmyx raised?
Cellmyx has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Cellmyx
PPP
Public-Private Partnership
What's next for Cellmyx?
Following this late-stage financing, Cellmyx is well-positioned to accelerate its market penetration and operational footprint. The strategic allocation of this capital will likely focus on expanding manufacturing capacity to meet rising global demand for adipose-derived regenerative therapies. Furthermore, the company is expected to leverage these resources to refine its supply chain logistics and potentially invest in R&D to broaden its suite of surgical tools. As the medical aesthetics market continues to evolve, Cellmyx remains a pivotal player, poised to capitalize on the increasing integration of fat transfer technologies in both reconstructive and cosmetic surgical applications.
See full Cellmyx company page
